title: [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
authors.forename: Olof
authors.initials: O
authors.lastname: Edhag
authors.forename: Anders
authors.initials: A
authors.lastname: Norlund
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy*; D000077265:Donepezil; D019317:Evidence-Based Medicine; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil